Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Lung Neoplasms × belagenpumatucel L × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Interventional 2 Expanded_access 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

trilaciclib 1 taletrectinib 1 lazertinib 1 dabrafenib 1 capmatinib 1 brigatinib 1 belagenpumatucel L 1 Suspensions 1 Powders 1 Paclitaxel 1 BID protein, human 1 AMG 757 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01279798 2011-03-01

Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L)

NovaRx Corporation

No longer available

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡